Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Resectable Non-small Cell Lung Cancer × osimertinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 16 Lung Neoplasms 6 Small Cell Lung Carcinoma 1 Resectable Non-small Cell Lung Cancer 1 Recurrence 1 Rare Tumour 1 Neoplastic Cells, Circulating 1 Neoplasm, Residual 1 NSCLC 1 Meningeal Carcinomatosis 1 Brain Neoplasms 1

Interventions

sintilimab 1 osimertinib 1 Surgical Procedures, Operative 1 Platinum Compounds 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07038460 2025-06-26

NEO-LISI

Guangdong Provincial People's Hospital

Phase 2 Not yet recruiting

Resectable Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡